 Connection
Andrew Morris to Alkanesulfonic Acids
This is a "connection" page, showing publications Andrew Morris has written about Alkanesulfonic Acids.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.220 |
|
|
|
-
Petriello MC, Mottaleb MA, Serio TC, Balyan B, Cave MC, Pavuk M, Birnbaum LS, Morris AJ. Serum concentrations of legacy and emerging per- and polyfluoroalkyl substances in the Anniston Community Health Surveys (ACHS I and ACHS II). Environ Int. 2022 01; 158:106907.
Score: 0.771
-
Morgan S, Mottaleb MA, Kraemer MP, Moser DK, Worley J, Morris AJ, Petriello MC. Effect of lifestyle-based lipid lowering interventions on the relationship between circulating levels of per-and polyfluoroalkyl substances and serum cholesterol. Environ Toxicol Pharmacol. 2023 Mar; 98:104062.
Score: 0.209
-
Deng P, Wang C, Wahlang B, Sexton T, Morris AJ, Hennig B. Co-exposure to PCB126 and PFOS increases biomarkers associated with cardiovascular disease risk and liver injury in mice. Toxicol Appl Pharmacol. 2020 12 15; 409:115301.
Score: 0.179
-
Sims CR, Sehgal N, Turner D, Havens LA, Morris AJ, Shankar K, Pearson KJ, Everson TM, Andres A. Individual and mixtures of PFAS during pregnancy are associated with maternal cardiometabolic outcomes during pregnancy. Environ Health. 2025 Apr 30; 24(1):26.
Score: 0.061
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|